JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB52101

Recombinant human Cleaved Caspase-3 protein (Active)

Be the first to review this product! Submit a review

|

(9 Publications)

Recombinant human Cleaved Caspase-3 protein (Active) is a Human Full Length protein, in the 1 to 277 aa range, expressed in Escherichia coli, with >95%, suitable for FuncS.

View Alternative Names

CPP32, CASP3, Caspase-3, CASP-3, Apopain, Cysteine protease CPP32, Protein Yama, SREBP cleavage activity 1, CPP-32, SCA-1

1 Images
Western blot - Recombinant human Cleaved Caspase-3 protein (Active) (AB52101)
  • WB

Lab

Western blot - Recombinant human Cleaved Caspase-3 protein (Active) (AB52101)

This blot was produced using a 4-12% Bis-tris gel under the MES buffer system. The gel was run at 200V for 35 minutes before being transferred onto a Nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour using 2% Bovine Serum Albumin before being incubated with ab195905 overnight at 4°C. Antibody binding to the target was detected using a HRP conjugated streptavidin amplification step, and visualised using ECL development solution ab133406.

All lanes:

Western blot - Biotin Anti-Caspase-3 antibody [E87] (<a href='/en-us/products/primary-antibodies/biotin-caspase-3-antibody-e87-ab195905'>ab195905</a>) at 1/10000 dilution

All lanes:

Western blot - Recombinant human Cleaved Caspase-3 protein (Active) (ab52101) at 0.1 µg

Predicted band size: 31 kDa

Observed band size: 15 kDa

true

Exposure time: 10s

Key facts

Purity

>95% SDS-PAGE

Expression system

Escherichia coli

Tags

His tag N-Terminus His tag C-Terminus

Applications

FuncS

applications

Biologically active

Yes

Biological activity

Specific activity: ≥ 15,000 units/mg

Unit definition: One unit of the recombinant caspase-3 is the enzyme activity that cleaves 1 nmol of the caspase substrate DEVD-pNA (pNA: pnitroanaline) per hour at 37oC in a reaction solution containing 50 mM Hepes, pH 7.2, 50 mM NaCl, 0.1% Chaps, 10 mM EDTA, 5% Glycerol, and 10 mM DTT.

Accession

P42574

Animal free

No

Carrier free

No

Species

Human

Reconstitution

Reconstitute in water

Storage buffer

Constituents: PBS, 5% Glycerol (glycerin, glycerine), 1.71% HEPES, 1.71% Sodium chloride, 0.16% EDTA, 0.12% (R*,R*)-1,4-Dimercaptobutan-2,3-diol, 0.1% 3-[(3-Cholamidopropyl)dimethylammonio]-1-propanesulfonate

storage-buffer

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "FuncS": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p>We recommend using 1 unit/assay for analyzing caspase activity.</p>" } } }

Product details

This product is manufactured by BioVision, an Abcam company and was previously called 1083 Caspase-3, human recombinant. 1083-100 is the same size as the 100 unit size of ab52101.

The recombinant active human Caspase 3 spontaneously undergoes autoprocessing to yield subunits characteristic of the native enzyme.

Cleaved Caspase 3 is useful in studying enzyme regulation, determining target substrates, screening caspase inhibitors, or as a positive control in caspase activity assays. The active Caspase 3 preferentially cleaves Caspase 3 substrates e.g. DEVD-AFC or DEVD-pNA.

MW: large (17 kD) and small (11 kD) subunits.

Sequence info

[{"sequence":"MENTENSVDSKSIKNLEPKIIHGSESMDSGISLDNSYKMDYPEMGLCIIINNKNFHKSTGMTSRSGTDVDAANLRETFRNLKYEVRNKNDLTREEIVELMRDVSKEDHSKRSSFVCVLLSHGEEGIIFGTNGPVDLKKITNFFRGDRCRSLTGKPKLFIIQACRGTELDCGIETDSGVDDDMACHKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKQYADKLEFMHILTRVNRKVATEFESFSFDATFHAKKQIPCIVSMLTKELYFYH","proteinLength":"Full Length","predictedMolecularWeight":null,"actualMolecularWeight":null,"aminoAcidEnd":277,"aminoAcidStart":1,"nature":"Recombinant","expressionSystem":"Escherichia coli","accessionNumber":"P42574","tags":[{"tag":"His","terminus":"N-Terminus"},{"tag":"His","terminus":"C-Terminus"}]}]

Properties and storage information

Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
-80°C
Appropriate long-term storage conditions
-80°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle
True

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The Cleaved Caspase-3 also known as active caspase 3 plays an important role in the execution phase of cell apoptosis. The caspase 3 molecule has a molecular weight of approximately 32 kDa. It undergoes cleavage into subunits that are important for its activation marking its conversion into the cleaved form. Cleaved caspase is widely expressed in various tissues with a notable presence in the cytoplasm of cells undergoing apoptotic processes. Cleavage of caspase 3 results in the formation of a functional enzyme that participates in the degradation of cellular components during apoptosis.
Biological function summary

Caspase 3 acts as an executioner enzyme in the process of programmed cell death. Its cleavage from the inactive zymogen form into the active form triggers apoptotic pathways ensuring the removal of damaged or unnecessary cells. Cleaved caspase operates within a proteolytic cascade often in conjunction with other caspases such as caspase 9. Once activated caspase 3 targets and cleaves specific cellular substrates contributing to the characteristic morphological changes and DNA fragmentation associated with apoptosis.

Pathways

Cleaved caspase 3 is significant within the intrinsic and extrinsic apoptotic pathways. It acts downstream of initiator caspases such as caspase 9 in the intrinsic pathway where its activation involves mitochondrial signals. In the extrinsic pathway it closely associates with caspase 8 mediating cell death signals from extracellular triggers. These pathways ensure that cleaved caspase 3 fulfills its role as a critical mediator of apoptosis linking upstream death signals to cellular dismantling during the apoptosis process.

Cleaved caspase 3 connects to conditions such as cancer and neurodegenerative diseases. In cancer dysregulation of caspase 3 activity may lead to evasion of apoptosis facilitating tumor progression. Therapeutic approaches aim to restore its apoptotic functions in cancer cells. In neurodegenerative diseases like Alzheimer's disease abnormal activation of cleaved caspase 3 contributes to neuronal loss. It interacts with proteins like amyloid precursor protein promoting the pathological changes associated with this disorder. Understanding these interactions provides insights into potential therapeutic avenues.

Specifications

Form

Lyophilized

General info

Function

Thiol protease that acts as a major effector caspase involved in the execution phase of apoptosis (PubMed : 18723680, PubMed : 20566630, PubMed : 23650375, PubMed : 35338844, PubMed : 35446120, PubMed : 7596430). Following cleavage and activation by initiator caspases (CASP8, CASP9 and/or CASP10), mediates execution of apoptosis by catalyzing cleavage of many proteins (PubMed : 18723680, PubMed : 20566630, PubMed : 23650375, PubMed : 7596430). At the onset of apoptosis, it proteolytically cleaves poly(ADP-ribose) polymerase PARP1 at a '216-Asp-|-Gly-217' bond (PubMed : 10497198, PubMed : 16374543, PubMed : 7596430, PubMed : 7774019). Cleaves and activates sterol regulatory element binding proteins (SREBPs) between the basic helix-loop-helix leucine zipper domain and the membrane attachment domain (By similarity). Cleaves and activates caspase-6, -7 and -9 (CASP6, CASP7 and CASP9, respectively) (PubMed : 7596430). Cleaves and inactivates interleukin-18 (IL18) (PubMed : 37993714, PubMed : 9334240). Involved in the cleavage of huntingtin (PubMed : 8696339). Triggers cell adhesion in sympathetic neurons through RET cleavage (PubMed : 21357690). Cleaves and inhibits serine/threonine-protein kinase AKT1 in response to oxidative stress (PubMed : 23152800). Acts as an inhibitor of type I interferon production during virus-induced apoptosis by mediating cleavage of antiviral proteins CGAS, IRF3 and MAVS, thereby preventing cytokine overproduction (PubMed : 30878284). Also involved in pyroptosis by mediating cleavage and activation of gasdermin-E (GSDME) (PubMed : 35338844, PubMed : 35446120). Cleaves XRCC4 and phospholipid scramblase proteins XKR4, XKR8 and XKR9, leading to promote phosphatidylserine exposure on apoptotic cell surface (PubMed : 23845944, PubMed : 33725486). Cleaves BIRC6 following inhibition of BIRC6-caspase binding by DIABLO/SMAC (PubMed : 36758104, PubMed : 36758106).

Sequence similarities

Belongs to the peptidase C14A family.

Post-translational modifications

Cleavage by granzyme B, caspase-6, caspase-8 and caspase-10 generates the two active subunits (PubMed:35338844, PubMed:35446120, PubMed:7596430, PubMed:8755496). Additional processing of the propeptides is likely due to the autocatalytic activity of the activated protease (PubMed:7596430, PubMed:8755496). Active heterodimers between the small subunit of caspase-7 protease and the large subunit of caspase-3 also occur and vice versa (PubMed:7596430, PubMed:8755496).. S-nitrosylated on its catalytic site cysteine in unstimulated human cell lines and denitrosylated upon activation of the Fas apoptotic pathway, associated with an increase in intracellular caspase activity. Fas therefore activates caspase-3 not only by inducing the cleavage of the caspase zymogen to its active subunits, but also by stimulating the denitrosylation of its active site thiol.. Ubiquitinated by BIRC6; this activity is inhibited by DIABLO/SMAC.. (Microbial infection) ADP-riboxanation by C.violaceum CopC blocks CASP3 processing, preventing CASP3 activation and ability to recognize and cleave substrates.

Product protocols

Target data

Thiol protease that acts as a major effector caspase involved in the execution phase of apoptosis (PubMed : 18723680, PubMed : 20566630, PubMed : 23650375, PubMed : 35338844, PubMed : 35446120, PubMed : 7596430). Following cleavage and activation by initiator caspases (CASP8, CASP9 and/or CASP10), mediates execution of apoptosis by catalyzing cleavage of many proteins (PubMed : 18723680, PubMed : 20566630, PubMed : 23650375, PubMed : 7596430). At the onset of apoptosis, it proteolytically cleaves poly(ADP-ribose) polymerase PARP1 at a '216-Asp-|-Gly-217' bond (PubMed : 10497198, PubMed : 16374543, PubMed : 7596430, PubMed : 7774019). Cleaves and activates sterol regulatory element binding proteins (SREBPs) between the basic helix-loop-helix leucine zipper domain and the membrane attachment domain (By similarity). Cleaves and activates caspase-6, -7 and -9 (CASP6, CASP7 and CASP9, respectively) (PubMed : 7596430). Cleaves and inactivates interleukin-18 (IL18) (PubMed : 37993714, PubMed : 9334240). Involved in the cleavage of huntingtin (PubMed : 8696339). Triggers cell adhesion in sympathetic neurons through RET cleavage (PubMed : 21357690). Cleaves and inhibits serine/threonine-protein kinase AKT1 in response to oxidative stress (PubMed : 23152800). Acts as an inhibitor of type I interferon production during virus-induced apoptosis by mediating cleavage of antiviral proteins CGAS, IRF3 and MAVS, thereby preventing cytokine overproduction (PubMed : 30878284). Also involved in pyroptosis by mediating cleavage and activation of gasdermin-E (GSDME) (PubMed : 35338844, PubMed : 35446120). Cleaves XRCC4 and phospholipid scramblase proteins XKR4, XKR8 and XKR9, leading to promote phosphatidylserine exposure on apoptotic cell surface (PubMed : 23845944, PubMed : 33725486). Cleaves BIRC6 following inhibition of BIRC6-caspase binding by DIABLO/SMAC (PubMed : 36758104, PubMed : 36758106).
See full target information CASP3

Publications (9)

Recent publications for all applications. Explore the full list and refine your search

Cancer biology & therapy 26:2459426 PubMed39878157

2025

Caspase 3-specific cleavage of ubiquitin-specific peptidase 48 enhances drug-induced apoptosis in AML.

Applications

Unspecified application

Species

Unspecified reactive species

Zhanglin Zhang,Xiang Lin,Yaling Yang,Xuemei Wang,Yi Wang,Xianbao Huang,Miao Hong,Wei Gao,Hua He,M James You,Yi Yang,Guangyao Kong

Nature methods 21:342-352 PubMed38191931

2024

Mapping enzyme activity in living systems by real-time mid-infrared photothermal imaging of nitrile chameleons.

Applications

Unspecified application

Species

Unspecified reactive species

Hongjian He,Jiaze Yin,Mingsheng Li,Chinmayee Vallabh Prabhu Dessai,Meihui Yi,Xinyan Teng,Meng Zhang,Yueming Li,Zhiyi Du,Bing Xu,Ji-Xin Cheng

Molecular therapy. Nucleic acids 33:548-558 PubMed37588686

2023

Cathepsin B-activatable cyclic antisense oligonucleotides for cell-specific target gene knockdown and .

Applications

Unspecified application

Species

Unspecified reactive species

Zhongyu Wang,Xinli Fan,Guanqun Mu,Xiaoran Zhao,Qian Wang,Jing Wang,Xinjing Tang

International journal of molecular sciences 24: PubMed37047634

2023

Pharmacological Targeting of Bcl-2 Induces Caspase 3-Mediated Cleavage of HDAC6 and Regulates the Autophagy Process in Colorectal Cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Donglin Yang,Liujun He,Shuiqing Ma,Shiqiang Li,Yajun Zhang,Chunsheng Hu,Jiuhong Huang,Zhigang Xu,Dianyong Tang,Zhongzhu Chen

Cell & bioscience 12:122 PubMed35918763

2022

AKT phosphorylation as a predictive biomarker for PI3K/mTOR dual inhibition-induced proteolytic cleavage of mTOR companion proteins in small cell lung cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Ming-Chun Hung,Wan-Ping Wang,Ya-Hui Chi

Molecular cell 82:785-802.e10 PubMed35104452

2022

SPARCLE, a p53-induced lncRNA, controls apoptosis after genotoxic stress by promoting PARP-1 cleavage.

Applications

Unspecified application

Species

Unspecified reactive species

Karla F Meza-Sosa,Rui Miao,Francisco Navarro,Zhibin Zhang,Ying Zhang,Jun Jacob Hu,Corrine Corrina R Hartford,Xiao Ling Li,Gustavo Pedraza-Alva,Leonor Pérez-Martínez,Ashish Lal,Hao Wu,Judy Lieberman

Experimental cell research 370:103-115 PubMed29908160

2018

Pseudo-phosphorylation at AT8 epitopes regulates the tau truncation at aspartate 421.

Applications

Unspecified application

Species

Unspecified reactive species

Lan Cao,Yan Liang,Yunsheng Liu,Yuxia Xu,Wenbin Wan,Cuiqing Zhu

ACS chemical biology 13:761-771 PubMed29365249

2018

Toward a Microparticle-Based System for Pooled Assays of Small Molecules in Cellular Contexts.

Applications

Unspecified application

Species

Unspecified reactive species

Carrie E Yozwiak,Tal Hirschhorn,Brent R Stockwell

Biochimica et biophysica acta 1840:191-8 PubMed24035784

2013

Implications of the O-GlcNAc modification in the regulation of nuclear apoptosis in T cells.

Applications

Unspecified application

Species

Unspecified reactive species

Bruno Johnson,Marlyse Opimba,Jacques Bernier
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com